# Validation of RDQ Questionnaire

> **NCT00291746** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 350 (—)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Esomeprazole
- **PROCEDURE:** Bravo technique

## Key facts

- **NCT ID:** NCT00291746
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 350 (—)
- **Last updated:** 2009-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291746, "Validation of RDQ Questionnaire". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00291746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*